全文获取类型
收费全文 | 1041篇 |
免费 | 40篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 56篇 |
妇产科学 | 43篇 |
基础医学 | 110篇 |
口腔科学 | 12篇 |
临床医学 | 63篇 |
内科学 | 235篇 |
皮肤病学 | 7篇 |
神经病学 | 102篇 |
特种医学 | 58篇 |
外科学 | 184篇 |
综合类 | 28篇 |
预防医学 | 33篇 |
眼科学 | 11篇 |
药学 | 42篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 92篇 |
出版年
2024年 | 9篇 |
2023年 | 9篇 |
2022年 | 16篇 |
2021年 | 18篇 |
2020年 | 14篇 |
2019年 | 29篇 |
2018年 | 26篇 |
2017年 | 21篇 |
2016年 | 28篇 |
2015年 | 25篇 |
2014年 | 29篇 |
2013年 | 50篇 |
2012年 | 69篇 |
2011年 | 74篇 |
2010年 | 31篇 |
2009年 | 38篇 |
2008年 | 51篇 |
2007年 | 55篇 |
2006年 | 51篇 |
2005年 | 34篇 |
2004年 | 57篇 |
2003年 | 50篇 |
2002年 | 41篇 |
2001年 | 29篇 |
2000年 | 34篇 |
1999年 | 24篇 |
1998年 | 6篇 |
1997年 | 6篇 |
1996年 | 10篇 |
1995年 | 7篇 |
1994年 | 6篇 |
1992年 | 7篇 |
1991年 | 5篇 |
1990年 | 10篇 |
1989年 | 11篇 |
1988年 | 7篇 |
1987年 | 9篇 |
1986年 | 7篇 |
1985年 | 16篇 |
1984年 | 8篇 |
1983年 | 7篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1979年 | 9篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1974年 | 4篇 |
1973年 | 4篇 |
1971年 | 4篇 |
排序方式: 共有1085条查询结果,搜索用时 15 毫秒
41.
Lata Kaphalia;Mukund P. Srinivasan;Bhupendra S. Kaphalia;William J. Calhoun; 《Alcoholism, clinical and experimental research》2024,48(4):596-611
Chronic alcohol consumption/misuse is a significant risk factor for pneumonia and lung infection leading to the development of chronic pulmonary disorders such as chronic obstructive pulmonary disease (COPD) and lung fibrosis. In this study, we sought to delineate the mechanism of alcohol-associated lung disease. We did so by measuring in vitro mitochondrial, endoplasmic reticulum (ER) oxidative stress in human bronchial epithelial cells (hBECs) treated with ethanol and its oxidative (acetaldehyde) and nonoxidative (fatty acid ethyl esters or FAEEs) metabolites. 相似文献
42.
Ravikumar Aalinkeel Bindukumar Nair Chih‐Kuang Chen Supriya D. Mahajan Jessica L. Reynolds Hanguang Zhang Haotian Sun Donald E. Sykes Kailash C. Chadha Steven G. Turowski Katelyn D. Bothwell Mukund Seshadri Chong Cheng Stanley A. Schwartz 《Immunology》2016,148(4):387-406
Interleukin‐8 (IL‐8) is a pro‐angiogenic cytokine associated with aggressive prostate cancer (CaP). We detected high levels of IL‐8 in sera from patients with CaP compared with healthy controls and patients with benign prostatic hypertrophy. This study examines the role of IL‐8 in the pathogenesis of metastatic prostate cancer. We developed a biocompatible, cationic polylactide (CPLA) nanocarrier to complex with and efficiently deliver IL‐8 small interfering RNA (siRNA) to CaP cells in vitro and in vivo. CPLA IL‐8 siRNA nanocomplexes (nanoplexes) protect siRNA from rapid degradation, are non‐toxic, have a prolonged lifetime in circulation, and their net positive charge facilitates penetration of cell membranes and subsequent intracellular trafficking. Administration of CPLA IL‐8 siRNA nanoplexes to immunodeficient mice bearing human CaP tumours produced significant antitumour activities with no adverse effects. Systemic (intravenous) or local intra‐tumour administration of IL‐8 siRNA nanoplexes resulted in significant inhibition of CaP growth. Magnetic resonance imaging and ultrasonography of experimental animals demonstrated reduction of tumour perfusion in vivo following nanoplex treatment. Staining of tumour sections for CD31 confirmed significant damage to tumour neovasculature after nanoplex therapy. These studies demonstrate the efficacy of IL‐8 siRNA nanotherapy for advanced, treatment‐resistant human CaP. 相似文献
43.
M. E. Jacobson;R. S. Seshadri;R. Morimoto;E. Grinich;C. Haag;K. Nguyen;E. L. Simpson; 《Journal of the European Academy of Dermatology and Venereology》2024,38(4):665-672
Atopic dermatitis (AD) is a highly prevalent chronic inflammatory skin disease representing a major source of global disability burden. Disease-modifying therapies are showing promise in chronic inflammatory disorders such as rheumatoid arthritis and Crohn's disease with method and timing of initial treatment impacting long-term disease outcomes. Whether disease-modifying therapies, specifically those used as an early interventional approach, impacts disease course and comorbidity development in AD is not well-understood. We reviewed the progress in disease modification strategies, emphasizing early intervention approaches in common (or proto-typical) inflammatory diseases. Although more common in other fields, disease modification approaches are becoming increasingly investigated in dermatology, though studies in AD are lacking. Despite significant limitations in ongoing and completed studies, early data are promising and suggest that both the choice and timing of early intervention approach can affect long-term disease course and comorbidity development. To best improve AD patient outcomes, more research is needed to further explore the impact of early disease-modifying therapies. Future studies should focus on identifying the most effective approaches and extend the early results to a more inclusive set of comorbidities and longer-term outcomes. 相似文献
44.
Yashwant Patidar Chandan Kumar Pal Amar Mukund Guresh Kumar Shiv Kumar Sarin 《The British journal of radiology》2021,94(1120)
Objective:Comparing the efficacy, safety and outcome of percutaneous intrervention for Budd-Chiari Syndrome (BCS) patients with bilirubin less than 3 and 3–6 mg dl−1.Methods and materials:188 BCS patients having serum bilirubin ≤6 mg dl−1 and underwent percutaneous interventions were divided into two groups based on bilirubin level: 151 patients having bilirubin <3 mg dl−1 were included in Group 1; and 37 patients having bilirubin 3–6 mg dl−1 were included in Group 2. Both group were compare for technical success (successful recanalization of hepatic venous stenosis or creation of portocaval shunt with post-procedure gradient ≤5 mm of Hg), Safety (procedure-related mortality/morbidity or patient required transplantation) and outcome (resolution of clinical symptoms and survival).Results:Technical success was 94.7% in Group 1–89.1% in Group 2 with overall success rate was 93.6%. No significant differences observed between the two groups in regards to procedure related complication. Overall transplant-free survival at 1 and 5 years after intervention in both groups was 96.3 and 91.2% respectively. 1-year and 5-year survivals in Group 1 was 96.7%, and 93.1%, whereas Group 2 was 94.6 and 90.1% with no statically significantly difference between the two groups (p = 0.59). Percutaneous intervention results are good in patients having bilirubin up to 6 mg dl−1, i.e. mild to moderate liver dysfunctions.Conclusion:Technical success, survival and outcome of percutaneous intervention in BCS patients having serum bilirubin 3–6 mg dl−1 was comparable to patients having bilirubin level <3 mg dl−1.Advances in knowledge:Percutaneous intervention treatment is suitable for treatment for symptomatic BCS patients having bilirubin up to 6 mg dl−1. 相似文献
45.
Danielle L Heidemann Angie Adhami Anupama Nair Alexis Haftka-George Mariam Zaidan Vaidehi Seshadri Amy Tang David E. Willens 《Journal of general internal medicine》2021,36(9):2608
BackgroundCervical cancer is the third most common malignancy affecting women. Screening with Papanicolaou (Pap) tests effectively identifies precancerous lesions and early-stage cervical cancer. While the nationwide rate of cervical cancer screening (CCS) is 84%, our urban general internal medicine (GIM) clinic population had a CCS rate of 70% in 2016.ObjectiveTo improve our clinic’s CCS rate to match or exceed the national average within 18 months by identifying barriers and testing solutions.DesignA quality improvement project led by a multidisciplinary group of healthcare providers.ParticipantsOur GIM clinic includes 16 attending physicians, 116 resident physicians, and 20 medical assistants (MAs) with an insured and underserved patient population.InterventionPhase 1 lasted 9 months and implemented CCS patient outreach, patient financial incentives, and clinic staff education. Phase 2 lasted 9 months and involved a workflow change in which MAs identified candidates for CCS during patient check-in. Feedback spanned the entire study period.Main MeasuresOur primary outcome was the number of Pap tests completed per month during the 2 study phases. Our secondary outcome was the clinic population’s CCS rate for all eligible clinic patients.Key ResultsAfter interventions, the average number of monthly Pap tests increased from 35 to 56 in phase 1 and to 75 in phase 2. Of 385 patients contacted in phase 1, 283 scheduled a Pap test and 115 (41%) completed it. Compared to baseline, both interventions improved cervical cancer screening (phase 1 relative risk, 1.86; 95% CI, 1.64–2.10; P < 0.001; phase 2 relative risk, 2.70; 95% CI, 2.40–3.02; P < 0.001). Our clinic’s CCS rate improved from 70% to 75% after the 18-month intervention.ConclusionsThe rate of CCS increased by 5% after a systematic 2-phase organizational intervention that empowered MAs to remind, identify, and prepare candidates during check-in for CCS.KEY WORDS: cervical cancer screening, organizational intervention, quality improvement, prevention, multidisciplinary team care 相似文献
46.
Lunetta KL D'Agostino RB Karasik D Benjamin EJ Guo CY Govindaraju R Kiel DP Kelly-Hayes M Massaro JM Pencina MJ Seshadri S Murabito JM 《BMC medical genetics》2007,8(Z1):S13
Background
Family studies and heritability estimates provide evidence for a genetic contribution to variation in the human life span.Methods
We conducted a genome wide association study (Affymetrix 100K SNP GeneChip) for longevity-related traits in a community-based sample. We report on 5 longevity and aging traits in up to 1345 Framingham Study participants from 330 families. Multivariable-adjusted residuals were computed using appropriate models (Cox proportional hazards, logistic, or linear regression) and the residuals from these models were used to test for association with qualifying SNPs (70, 987 autosomal SNPs with genotypic call rate ≥80%, minor allele frequency ≥10%, Hardy-Weinberg test p ≥ 0.001).Results
In family-based association test (FBAT) models, 8 SNPs in two regions approximately 500 kb apart on chromosome 1 (physical positions 73,091,610 and 73, 527,652) were associated with age at death (p-value < 10-5). The two sets of SNPs were in high linkage disequilibrium (minimum r2 = 0.58). The top 30 SNPs for generalized estimating equation (GEE) tests of association with age at death included rs10507486 (p = 0.0001) and rs4943794 (p = 0.0002), SNPs intronic to FOXO1A, a gene implicated in lifespan extension in animal models. FBAT models identified 7 SNPs and GEE models identified 9 SNPs associated with both age at death and morbidity-free survival at age 65 including rs2374983 near PON1. In the analysis of selected candidate genes, SNP associations (FBAT or GEE p-value < 0.01) were identified for age at death in or near the following genes: FOXO1A, GAPDH, KL, LEPR, PON1, PSEN1, SOD2, and WRN. Top ranked SNP associations in the GEE model for age at natural menopause included rs6910534 (p = 0.00003) near FOXO3a and rs3751591 (p = 0.00006) in CYP19A1. Results of all longevity phenotype-genotype associations for all autosomal SNPs are web posted at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007.Conclusion
Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are proposed as contributing to longevity and healthy aging.47.
48.
49.
Early detection has a central role in the prevention and management of mental retardation. The purpose of this present study
is to delinerate the characteristics of developmentally delayed infants and their families attending Mental Retardation Clinic.
The sample consisted of 101 infants who were registered in Mental Retardation Clinic of NIMHANS, Bangalore in 1988 constituting
12.5% of total registrations. Data was collected from case records.
Majority of subjects were males, first or second born, 7 months or older, from a consanguineous lower or middle class family.
Along with developmental delay, 60% had other complaints. Medical problems were reported in about half of the subjects and
most had abnormalities on physical examination. Aetiology was discernible in 77.1%. Majority had associated physical disorder
such as cerebral palsy, seizures and hearing and/or visual impairment. Around 17% came for follow-up thrice or more, 43% dropped
out after work-up.
The main conclusions are that; (i) certain socio-demographic, personal and clinical variables influence treatment seeking,
and (ii) developmental delay recognised in infancy tends to be associated with clear aetiologic factors and significant medical/neurologic
problems. 相似文献
50.
Susan G. Weinberg Alan Lubin Stephen N. Wiener Mukund P. Deoras Manash K. Ghose Robert C. Kopelman 《The American journal of medicine》1977
A young patient with chronic renal failure, pancytopenia and hepatosplenomegaly with hypersplenism had evidence of severe renal osteodystrophy on x-ray films and a bone marrow biopsy specimen resembling myelofibrosis. Hematologic improvement followed splenectomy and was sustained following renal transplantation. 相似文献